The Column Group has been a busy venture player in the biotech world. And the VC plans to stay busy. In a recent filing at the FDA, the venture group revealed that it has raised close to $176 million out of a planned $250 million fund.

…read more

Source: Column Group nears goal line for $250M biotech venture fund


0 No comments